| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $1,224,096 | 9 | 69 |
Sells | $3,488,437 | 4 | 31 |
| COLLIS STEVEN H | director | 1 | $267,150 | 0 | $0 | $267,150 |
| SAUNDERS BRENT L | CEO and Chairman of the Board | 1 | $251,958 | 0 | $0 | $251,958 |
| Bailey A Robert D | EVP & Chief Legal Officer | 1 | $250,332 | 0 | $0 | $250,332 |
| VON ESCHENBACH ANDREW C. | director | 1 | $79,883 | 2 | $306,708 | $-226,825 |
| Ross Thomas W. Sr. | director | 1 | $79,556 | 0 | $0 | $79,556 |
| ROBERTSON RUSSEL C | director | 1 | $78,760 | 0 | $0 | $78,760 |
| Alfonso Eduardo | director | 1 | $76,970 | 0 | $0 | $76,970 |
| Ling Karen | director | 1 | $70,968 | 0 | $0 | $70,968 |
| Eldessouky Sam | EVP and CFO | 1 | $68,520 | 0 | $0 | $68,520 |
| Munsch Frederick | SVP, Controller and CAO | 0 | $0 | 2 | $3.18M | $-3.18M |
Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment also provides essential contact lens care products, over-the-counter eye drops, and nutritional supplements aimed at alleviating common eye conditions like …
Over the last 12 months, insiders at Bausch + Lomb Corporation have bought $1.22M and sold $3.49M worth of Bausch + Lomb Corporation stock.
On average, over the past 5 years, insiders at Bausch + Lomb Corporation have bought $665,720 and sold $676.28M worth of stock each year.
Highest buying activity among insiders over the last 12 months: COLLIS STEVEN H (director) — $267,150. SAUNDERS BRENT L (CEO and Chairman of the Board) — $251,958. Bailey A Robert D (EVP & Chief Legal Officer) — $250,332.
The last purchase of 14,700 shares for transaction amount of $251,958 was made by SAUNDERS BRENT L (CEO and Chairman of the Board) on 2026‑03‑06.
| 2026-10-29 | Sale | Munsch Frederick | SVP, Controller and CAO | 112,015 0.0314% | $20.48 | $2.29M | -1.91% | |
| 2026-08-10 | Sale | Munsch Frederick | SVP, Controller and CAO | 52,900 0.0148% | $16.78 | $887,662 | +2.08% | |
| 2026-08-07 | Sale | VON ESCHENBACH ANDREW C. | director | 6,059 0.0017% | $16.58 | $100,458 | +2.38% | |
| 2026-08-06 | Sale | VON ESCHENBACH ANDREW C. | director | 12,500 0.0035% | $16.50 | $206,250 | +5.05% | |
| 2026-03-06 | SAUNDERS BRENT L | CEO and Chairman of the Board | 14,700 0.0042% | $17.14 | $251,958 | -2.93% | ||
| 2026-03-06 | Eldessouky Sam | EVP and CFO | 4,000 0.0011% | $17.13 | $68,520 | -2.93% | ||
| 2026-03-06 | Bailey A Robert D | EVP & Chief Legal Officer | 14,600 0.0041% | $17.15 | $250,332 | -2.93% | ||
| 2026-03-03 | Ross Thomas W. Sr. | director | 4,500 0.0012% | $17.68 | $79,556 | -7.76% | ||
| 2026-03-02 | Alfonso Eduardo | director | 4,300 0.0012% | $17.90 | $76,970 | -9.89% | ||
| 2026-02-27 | VON ESCHENBACH ANDREW C. | director | 4,364 0.0012% | $18.30 | $79,883 | -9.29% | ||
| 2026-02-23 | COLLIS STEVEN H | director | 15,000 0.0042% | $17.81 | $267,150 | -7.64% | ||
| 2026-02-20 | ROBERTSON RUSSEL C | director | 4,400 0.0012% | $17.90 | $78,760 | -7.36% | ||
| 2026-02-19 | Ling Karen | director | 4,000 0.0011% | $17.74 | $70,968 | -5.81% | ||
| 2025-05-22 | SAUNDERS BRENT L | CEO and Chairman of the Board | 22,000 0.0062% | $11.28 | $248,072 | +39.64% | ||
| 2025-05-02 | VON ESCHENBACH ANDREW C. | director | 1,695 0.0005% | $11.76 | $19,925 | +33.30% | ||
| 2024-08-05 | SAUNDERS BRENT L | CEO and Chairman of the Board | 32,250 0.0093% | $15.66 | $505,067 | +3.60% | ||
| 2022-06-01 | Sale | Bausch Health Companies Inc. | 9.1M 2.724% | $17.05 | $155.21M | -1.47% | ||
| 2022-05-10 | Sale | Bausch Health Companies Inc. | 70M 19.4359% | $17.05 | $1.19B | -8.60% |
| SAUNDERS BRENT L | CEO and Chairman of the Board | 966575 0.2704% | $19.36M | 3 | 0 | +21.62% |
| Eldessouky Sam | EVP and CFO | 403130 0.1128% | $8.07M | 1 | 0 | |
| Bailey A Robert D | EVP & Chief Legal Officer | 231890 0.0649% | $4.64M | 1 | 0 | |
| ROBERTSON RUSSEL C | director | 72407 0.0203% | $1.45M | 1 | 0 | |
| Ross Thomas W. Sr. | director | 64891 0.0182% | $1.3M | 1 | 0 | |
| VON ESCHENBACH ANDREW C. | director | 63733 0.0178% | $1.28M | 2 | 2 | +33.3% |
| Ling Karen | director | 41676 0.0117% | $834,770.28 | 1 | 0 | |
| COLLIS STEVEN H | director | 20255 0.0057% | $405,707.65 | 1 | 0 | |
| Alfonso Eduardo | director | 9555 0.0027% | $191,386.65 | 1 | 0 |
$167,495 | 10 | 32.53% | $50.79M | |
$8,662,717 | 6 | -49.85% | $7.36M | |
$858,500 | 3 | 13.15% | $1.73B | |
Bausch + Lomb Corporation (BLCO) | $773,064 | 3 | 25.52% | $7.16B |
$34,477,719 | 2 | -9.33% | $51.35M |
| Increased Positions | 51 | +45.54% | 5M | +12.42% |
| Decreased Positions | 46 | -41.07% | 4M | -10.96% |
| New Positions | 20 | New | 1M | New |
| Sold Out Positions | 14 | Sold Out | 3M | Sold Out |
| Total Postitions | 117 | +4.46% | 40M | +1.46% |
| Icahn Carl C | $58,030.00 | 0.99% | 3.5M | 0 | 0% | 2025-09-30 |
| Deutsche Bank Ag | $58,030.00 | 0.99% | 3.5M | +89,900 | +2.64% | 2025-09-30 |
| Oaktree Capital Management Lp | $53,809.00 | 0.92% | 3.25M | +724,194 | +28.72% | 2025-09-30 |
| Goldentree Asset Management Lp | $44,111.00 | 0.75% | 2.66M | +77,323 | +2.99% | 2025-09-30 |
| D. E. Shaw & Co., Inc. | $43,224.00 | 0.74% | 2.61M | 0 | 0% | 2025-09-30 |
| Silver Point Capital L.P. | $42,528.00 | 0.73% | 2.56M | +3M | New | 2025-09-30 |
| Fmr Llc | $25,867.00 | 0.44% | 1.56M | +788,291 | +102.13% | 2025-09-30 |
| Glenview Capital Management, Llc | $25,763.00 | 0.44% | 1.55M | 0 | 0% | 2025-09-30 |
| Nomura Holdings Inc | $20,827.00 | 0.36% | 1.26M | 0 | 0% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $20,509.00 | 0.35% | 1.24M | -12,347 | -0.99% | 2025-09-30 |